Patients w/ known sensitivity or allergy to fish. Thromboxane A2 production may fall during treatment. Monitor patients receiving anticoagulant or other drugs affecting coagulation (eg, ASA, warfarin & coumarin). Routine monitoring of the entire lipid profile; LDL-C especially in patients w/ type IV & V dyslipidemia. Not recommended as monotherapy in type IIb dyslipidemia. Regular monitoring of hepatic function (especially ALT) in patients w/ hepatic impairment. Pregnancy (category B1) & lactation. Childn & adolescent. Elderly ≥70 yr.